New whitepaper from PurpleLab illustrates how real world data can help life sciences companies successfully market new drug innovations to patients.
Life sciences companies are quickly developing new, innovative drugs. This progress has resulted new challenges for marketing teams that are charged with getting these new treatments to the patients who will benefit from them. This involves engaging with various stakeholders and ultimately leading healthcare providers to prescribe these innovative treatments.
To meet these new challenges, teams need to reinvent their go-to-market strategies. The key to successfully doing so? Real world data. This data can help marketing teams obtain a complete view of the healthcare ecosystem; illustrate value; understand the patient journey; and gain the insights required to make the right strategic decisions. More specifically, such data can be used to understand key phases of the patient journey including pre-origination, origination, evaluation, diagnosis, treatment choice, brand choice, fulfillment, and re-evaluation.
Offered Free by: PurpleLab
See All Resources from: PurpleLab